Methamphetamine-associated pulmonary arterial hypertension: data from the national biological sample and data repository for pulmonary arterial hypertension (PAH Biobank).
Methamphetamine-associated pulmonary arterial hypertension: data from the national biological sample and data repository for pulmonary arterial hypertension (PAH Biobank).
复制标题
DOI:
10.1136/bmjresp-2023-001917
复制
发表时间:
2023-12-07
影响因子:
4.1
通讯作者:
中科院分区:
文献类型:
--
作者:
This study compares the clinical and haemodynamic severity of methamphetamine-associated pulmonary arterial hypertension (MA-PAH) with idiopathic pulmonary arterial hypertension (IPAH) and connective tissue-associated pulmonary arterial hypertension (CTD-PAH). It also examines sex differences in clinical and physiological parameters among those with MA-PAH. This is a cross-sectional study using clinically derived data from the National Biological Sample and Data Repository for Pulmonary Arterial Hypertension (PAH biobank), a US-based registry, to compare clinical and physiological characteristics between males and females with MA-PAH. The analysis included 1830 patients enrolled in the PAH biobank, with a diagnosis of MA-PAH (n=42), IPAH (n=1073), or CTD-PAH (n=715). The study assessed and compared the clinical and haemodynamic parameters of patients with MA-PAH, IPAH and CTD-PAH. Among the patients analysed, 42 had MA-PAH, with 69.1% being female. There were no statistically significant differences in functional class among patients with MA-PAH, IPAH and CTD-PAH. The per cent predicted 6-min walk distance (6MWD) was comparable between the three groups. Patients with MA-PAH had similar mean pulmonary artery pressure and pulmonary vascular resistance to patients with IPAH but higher compared with patients with CTD-PAH. Male patients with MA-PAH exhibited a worse functional class and lower per cent predicted 6MWD, but no significant differences in haemodynamic findings were observed between the sexes. There were no differences in haemodynamic between MA-PAH and IPAH but we found that MA-PAH differed from CTD-PAH. The study did not find evidence of sex differences in MA-PAH. Further research is necessary to identify risk factors and underlying mechanisms of MA-PAH, particularly considering the increasing prevalence of methamphetamine use. Such investigations will contribute to the development of effective prevention and treatment strategies for this condition.
登录
查看更多内容
DOI:
10.1196/annals.1432.042
发表时间:
2008-01-01
期刊:
DRUG ADDICTION: RESEARCH FRONTIERS AND TREATMENT ADVANCES
影响因子:
--
作者:
Rothman, Richard B.;Zolkowska, Dorota;Baumann, Michael H.
通讯作者:
Baumann, Michael H.
DOI:
10.1183/13993003.04229-2020
发表时间:
2021-07
期刊:
The European respiratory journal
影响因子:
--
作者:
Montani D;Girerd B;Jaïs X;Laveneziana P;Lau EMT;Bouchachi A;Hascoët S;Günther S;Godinas L;Parent F;Guignabert C;Beurnier A;Chemla D;Hervé P;Eyries M;Soubrier F;Simonneau G;Sitbon O;Savale L;Humbert M
通讯作者:
Humbert M
影响因子:
3.9
作者:
Hser, YI;Evans, E;Huang, YC
通讯作者:
Huang, YC
影响因子:
24.3
作者:
Humbert, M;Deng, Z;Morse, JH
通讯作者:
Morse, JH
DOI:
10.1161/circep.121.010273
发表时间:
2022-01
期刊:
Circulation. Arrhythmia and electrophysiology
影响因子:
--
作者:
Dominic P;Ahmad J;Awwab H;Bhuiyan MS;Kevil CG;Goeders NE;Murnane KS;Patterson JC;Sandau KE;Gopinathannair R;Olshansky B
通讯作者:
Olshansky B